Correlation Between Revolution Medicines and Ultragenyx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Revolution Medicines and Ultragenyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Revolution Medicines and Ultragenyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Revolution Medicines and Ultragenyx, you can compare the effects of market volatilities on Revolution Medicines and Ultragenyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Revolution Medicines with a short position of Ultragenyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Revolution Medicines and Ultragenyx.

Diversification Opportunities for Revolution Medicines and Ultragenyx

-0.82
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Revolution and Ultragenyx is -0.82. Overlapping area represents the amount of risk that can be diversified away by holding Revolution Medicines and Ultragenyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ultragenyx and Revolution Medicines is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Revolution Medicines are associated (or correlated) with Ultragenyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ultragenyx has no effect on the direction of Revolution Medicines i.e., Revolution Medicines and Ultragenyx go up and down completely randomly.

Pair Corralation between Revolution Medicines and Ultragenyx

Given the investment horizon of 90 days Revolution Medicines is expected to generate 1.32 times more return on investment than Ultragenyx. However, Revolution Medicines is 1.32 times more volatile than Ultragenyx. It trades about 0.2 of its potential returns per unit of risk. Ultragenyx is currently generating about -0.16 per unit of risk. If you would invest  4,265  in Revolution Medicines on August 28, 2024 and sell it today you would earn a total of  1,485  from holding Revolution Medicines or generate 34.82% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Revolution Medicines  vs.  Ultragenyx

 Performance 
       Timeline  
Revolution Medicines 

Risk-Adjusted Performance

15 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Revolution Medicines are ranked lower than 15 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating primary indicators, Revolution Medicines exhibited solid returns over the last few months and may actually be approaching a breakup point.
Ultragenyx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ultragenyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Revolution Medicines and Ultragenyx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Revolution Medicines and Ultragenyx

The main advantage of trading using opposite Revolution Medicines and Ultragenyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Revolution Medicines position performs unexpectedly, Ultragenyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ultragenyx will offset losses from the drop in Ultragenyx's long position.
The idea behind Revolution Medicines and Ultragenyx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Complementary Tools

Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Bonds Directory
Find actively traded corporate debentures issued by US companies
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites